Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Positive clinical data supports Siga's unique vaccine delivery system

Nov. 25, 1998

Chiron reports phase II results of novel Meningococcus C vaccine trial

Nov. 24, 1998

Thalidomide analogue CC-3052 is more active, less toxic than parent drug

Nov. 23, 1998

Phase II data demonstrate efficacy of Avant's rotavirus vaccine

Nov. 23, 1998

SangCya launched in U.S. less than three weeks following approval

Nov. 20, 1998

Intellivax presents promising phase I data for intranasal vaccine for shigellosis

Nov. 20, 1998

New LYMErix study results point to faster immunization

Nov. 19, 1998

Axis Genetics enters collaboration for edible plant vaccine development

Nov. 18, 1998

BTG to commercialize new approach to bacterial vaccines

Nov. 16, 1998

Mizoribine evaluated in children with frequently relapsing nephrotic syndrome

Nov. 13, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...